The Health Saintenance system (Life Maintenance
System) is contolled at any time by biochemical
programs.
Georges DEBLED MD. demonstrated since 40 years
that a decrease of production in male hormones
produces and worsens the sexual involution in
man; cardiovascular diseases, arteriosclerosis,
angina pectoris, coronary thrombosis, high
sugar, high cholesterol and lipids in the blood;
arthrosis, stiffness and rheumatism in the joins
; nervous breakdown and involution of the brain.
Those phenomenons were described in two
pionneer-books by Dr Georges DEBLED : "
L'Andropause, cause, conséquences et remèdes",
Maloine, Paris 1988 et "Au-delà de cette
limite votre ticket est toujours valable",
Albin Michel, Paris 1992 et 1994.
In 1992, at an international congress on aging
in Dallas, Dr. Georges
DEBLED presented his theory, according to which
the fall in testosterone secretion is
responsible for male climacteric and ageing
illnesses (1-2).
1. DEBLED G.
The male climacteric, prime cause of sex
involution. The tenth annual international
symposium on man and his environment in health
and disease. February 27 - March 1, 1992,
Dallas. Texas. U.S.A.
2. DEBLED G.
The male climacteric, prime cause of aging.
The tenth annual international symposium on man
and his environment in health and disease.
February 27 - March 1, 1992, Dallas. Texas.
U.S.A.
Since this time many
scientific papers have confirmed this
work:
In
1997, the 21 INSERM Unit in France
confirmed the increase of
cardiovascular risk when testosterone secretion
is low in "healthy" adult man :
"Association between plasma total testoterone
and cardiovascular risk factors in healthy adult
men"
in the
Journal of
Clinical Endocrinology and Metabolism (Vol 82,
N° 2, p. : 682- 685). This
study known as the
Telecom
study investigated two groups of men during
8 years comparing their blood testosterone
levels. (download)
The first group
with normal testosterone during 8 years did not
show any increase of vascular risk during this
period.
T he second
group with a decrease of blood
testosterone along the 8 years demonstrated
a significative increase of
cardiovascular risk.
Recent
Publications confirming the hypogonadism of the
final phase of the andropause disease
|